genentech get ok drug immun ill genentech said friday receiv feder food drug administr approv market genet engin drug fight chronic granulomat diseas rare inherit disord immun system drug actimmun form interferon gamma first approv unit state interferon gamma product genentech third approv recombin drug market genentech develop actimmun orphan drug act give exclus right market particular diseas seven year compani use announc approv opportun reaffirm support act although presid bush earlier year veto one bill would alter act genentech expect addit challeng law actimmun market diseas blockbust south san francisco base compani although hope propos use interferon gamma prove import sourc revenu mani 400 children across countri suffer chronic granulomat diseas fda approv mean better chanc make adulthood rare immun system disord use call deadli granulomat often claim children reach age 12 larri hudson 13 year old diseas spend christma home prospect ore year week went snow tube first time ordinari event special mean larri parent laqueta daniel hudson laqueta hudson perhap make case continu support drug act elegantli compani could real bless drug said live terror anymor wait next infect strike larri one mani children receiv drug part clinic trial get inject three time week say like tri put even better readili admit go hassl pain previou drug treatment especi infect five year ago larri hospit two month includ christma recov surgeri remov larg growth brain treat mani small tumor like format lung caus diseas mani parent treatment cost devast especi inherit diseas often afflict one child famili dr john curnutt expert diseas conduct trial actimmun scripp clinic research foundat la jolla said trial drug 70 declin number seriou infect patient spent one third usual number day hospit hobb n two three children jeannen lenard wagner diseas drug approv excel christma present said jeannen wagner